<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">1027</id>
  <title>T3D1023</title>
  <common-name>Isodrin</common-name>
  <description>Isodrin is an exogenous organic compound with the formula C12H8Cl6 and an average molecular weight of 364.91 g/mol. It exists as a solid at room temperature. Isodrin belongs to the vinyl chlorides, a subclass of vinyl halides within the organic compounds. It has been recorded as a source of contamination in drinking water and water supplies, with oral exposure as a recorded route.

The compound interacts with 32 recorded protein targets. As an organochloride, it inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, including Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (ATP2A1), Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2), Calcium-transporting ATPase type 2C member 1 (ATP2C1), and Sodium/potassium-transporting ATPase subunit gamma (FXYD2). These proteins are essential for transporting calcium across membranes; their inhibition leads to the accumulation of intracellular free calcium ions, which promotes the release of neurotransmitters from storage vesicles, the depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. Additionally, isodrin antagonizes the action of the neurotransmitter gamma-aminobutyric acid (GABA) at GABA-A receptors, involving Gamma-aminobutyric acid receptor subunits alpha-1 (GABRA1), alpha-2 (GABRA2), alpha-3 (GABRA3), and alpha-4 (GABRA4), as well as 15 other proteins. This action blocks the GABA-induced uptake of chloride ions, resulting in hyperexcitability of the central nervous system. Isodrin also causes endocrine disruption in humans by binding to and inhibiting the Estrogen receptor (ESR1) and Estrogen receptor beta (ESR2).</description>
  <cas>465-73-6</cas>
  <pubchem-id>222548</pubchem-id>
  <chemical-formula>C12H8Cl6</chemical-formula>
  <weight>361.875720</weight>
  <appearance>White powder.</appearance>
  <melting-point>240-242°C</melting-point>
  <boiling-point></boiling-point>
  <density></density>
  <solubility></solubility>
  <specific-gravity></specific-gravity>
  <flash-point></flash-point>
  <vapour-pressure></vapour-pressure>
  <route-of-exposure></route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>It antagonizes the action of the neurotransmitter gamma-aminobutyric acid (GABA) acting at the GABA-A receptors, effectively blocking the GABA-induced uptake of chloride ions and causing hyperexcitability of the central nervous system. It also inhibits Na+ K+ ATPase and Ca2+ and Mg2+ ATPase which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. It also causes increased lipid peroxidation, decreased membrane fluidity, and DNA damage in hepatocytes, but the exact mechanism is unknown. (T10, L112)</mechanism-of-toxicity>
  <metabolism>It is absorbed orally and distributed primarily to the fat and skin. The major biotransformation product is anti-l 2-hydroxyendrin and the corresponding sulfate, as well as glucuronide metabolites. Anti- and syn-12-hydroxyendrin and 12-ketoendrin are the main toxic metabolites of endrin. It and its metabolites are excreted in urine and feces. (L112)</metabolism>
  <toxicity>LD50: 3 mg/kg (Oral, Rat) (T14) 
LD50: 12 mg/kg (Dermal, Rat) (T14)</toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>No indication of carcinogenicity (not listed by IARC). (L135)</carcinogenicity>
  <use-source>It is used as a pesticide. (L111) </use-source>
  <min-risk-level>Intermediate Oral: 0.002 mg/kg/day (L134) 
Chronic Oral: 0.0003 mg/kg/day (L134)</min-risk-level>
  <health-effects>Poisoning affects primarily the nerve system. Exposure causes various harmful effects including hyperexcitability, severe central nervous system damage, and death. It is also believed to cause birth defects. (T10, L112)</health-effects>
  <symptoms>Symptoms that may result from endrin poisoning are headaches, dizziness, nervousness, confusion, nausea, vomiting, and convulsions. (L112)</symptoms>
  <treatment>Treatment is symptomatic, aimed at controlling convulsions, coma, and respiratory depression. If ingested, gastric lavage may be performed, followed by administering activated charcoal powder. (L150)</treatment>
  <created-at type="dateTime">2009-06-18T04:16:52Z</created-at>
  <updated-at type="dateTime">2026-03-27T00:47:43Z</updated-at>
  <interacting-proteins></interacting-proteins>
  <wikipedia></wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id></ctd-id>
  <stitch-id>Isodrin</stitch-id>
  <drugbank-id></drugbank-id>
  <pdb-id></pdb-id>
  <actor-id>9726</actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>ClC1=C(Cl)C2(Cl)C3C4CC(C=C4)C3C1(Cl)C2(Cl)Cl</moldb-smiles>
  <moldb-formula>C12H8Cl6</moldb-formula>
  <moldb-inchi>InChI=1S/C12H8Cl6/c13-8-9(14)11(16)7-5-2-1-4(3-5)6(7)10(8,15)12(11,17)18/h1-2,4-7H,3H2</moldb-inchi>
  <moldb-inchikey>QBYJBZPUGVGKQQ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">364.91</moldb-average-mass>
  <moldb-mono-mass type="decimal">361.875716498</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp></logp>
  <hmdb-id></hmdb-id>
  <chembl-id></chembl-id>
  <chemspider-id></chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM000881</chemdb-id>
  <dsstox-id>DTXSID7042065</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00006421</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>0</moldb-polar-surface-area>
  <moldb-refractivity>79.75679999999998</moldb-refractivity>
  <moldb-polarizability>30.84545225163621</moldb-polarizability>
  <moldb-rotatable-bond-count>0</moldb-rotatable-bond-count>
  <moldb-acceptor-count>0</moldb-acceptor-count>
  <moldb-donor-count>0</moldb-donor-count>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>4</moldb-number-of-rings>
  <moldb-alogps-logp>5.90</moldb-alogps-logp>
  <moldb-alogps-logs>-6.65</moldb-alogps-logs>
  <moldb-alogps-solubility>8.11e-05 g/l</moldb-alogps-solubility>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organohalogen compounds</superklass>
  <klass>Vinyl halides</klass>
  <subklass>Vinyl chlorides</subklass>
  <paper-count type="integer">47</paper-count>
  <sync-id>CED0005737</sync-id>
  <structure-inchikey>QBYJBZPUGVGKQQ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000020000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000020400000000000000000000000000800000000000000000000000000000000008000000000800000000000000000020000000040000000000040100000000008000010000000000000000000000000000000000080000000000000000800000000000000000000080400000000000000000000000000000000040000000000000000000000000400000000000010000000000000000000000000000000000000800000000040000000000000000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAASAAAAFQAAAIABEQAgAAAAAQYAKAAAAAME
BgAoAAAAAwQRACAAAAABBgAgAAAABBEAIAAAAAEGAGAAAAADAQYAYAAAAAMB
BgBgAAAAAgIGAGAAAAADAQYAaAAAAAMDAQYAaAAAAAMDAQYAYAAAAAMBBgAg
AAAABBEAIAAAAAEGACAAAAAEEQAgAAAAAREAIAAAAAELAAEAAQIIAgIDAAIE
AAQFAAQGAAYHAAcIAAgJAAkKAAoLCAIJDAAMDQANDgANDwAPEAAPEQANAQAP
BAAMBgALBwBCBAAAAAUBAgQPDQUIBwYMCQUIBwsKCQUPDQwGBBcEAAAAAAAA
ABY=
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T03:59:57Z</structure-indexed-at>
</compound>
